Back to REGN

Rhenman & Partners Asset Management AB → REGN

Rhenman & Partners Asset Management AB REGN Position History

Regeneron Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$14.7M
Q3 2026
Peak value
$47.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$47.4M
Q1 2026$37.2M
Q2 2026$17.1M
Q3 2026$14.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$14.7M19.3K——
Q2 2026$17.1M27.4K——
Q1 2026$37.2M48.1K——
Q4 2025$47.4M61.4K——

Other funds holding REGN

Other Rhenman & Partners Asset Management AB positions

LLY

LILLY ELI & CO

$45.4M
BSX

BOSTON SCIENTIFIC CORP

$41.1M
BSX

BOSTON SCIENTIFIC CORP

$39.2M
UNH

UNITED HEALTH GROUP INC

$38.9M
JPM-PM

IOVANCE BIOTHERAPEUTICS INC

$37.1M
LLY

LILLY ELI & CO

$31M
AZN

ASTRAZENECA PLC

$30.3M
MRK

MERCK & CO. INC

$30.1M